Chronic rhinosinusitis is associated with prolonged SARS‐CoV‐2 RNA shedding in upper respiratory tract samples: A case‐control study
Background SARS‐CoV‐2, the COVID‐19 causative agent, has infected millions of people and killed over 1.6 million worldwide. A small percentage of cases persist with prolonged positive RT‐PCR on nasopharyngeal swabs. The aim of this study was to determine risk factors for prolonged viral shedding amo...
Gespeichert in:
| Veröffentlicht in: | Journal of internal medicine 2021-06, Vol.289 (6), p.921-925 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 925 |
|---|---|
| container_issue | 6 |
| container_start_page | 921 |
| container_title | Journal of internal medicine |
| container_volume | 289 |
| creator | Recalde‐Zamacona, B. Tomás‐Velázquez, A. Campo, A. Satrústegui‐Alzugaray, B. Fernández‐Alonso, M. Iñigo, M. Rodríguez‐Mateos, M. Di Frisco, M. Felgueroso, C. Bertó, J. Marín‐Oto, M. Alcaide, A. B. Zulueta, J. J. Seijo, L. Landecho, M. F. |
| description | Background
SARS‐CoV‐2, the COVID‐19 causative agent, has infected millions of people and killed over 1.6 million worldwide. A small percentage of cases persist with prolonged positive RT‐PCR on nasopharyngeal swabs. The aim of this study was to determine risk factors for prolonged viral shedding amongst patient’s basal clinical conditions.
Methods
We have evaluated all 513 patients attended in our hospital between 1 March and 1 July. We have selected all 18 patients with prolonged viral shedding and compared them with 36 sex‐matched randomly selected controls. Demographic, treatment and clinical data were systematically collected.
Results
Global median duration of viral clearance was 25.5 days (n = 54; IQR, 22–39.3 days), 48.5 days in cases (IQR 38.7–54.9 days) and 23 days in controls (IQR 20.2–25.7), respectively. There were not observed differences in demographic, symptoms or treatment data between groups.
Chronic rhinosinusitis and atopy were more common in patients with prolonged viral shedding (67%) compared with controls (11% and 25% respectively) (P |
| doi_str_mv | 10.1111/joim.13237 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2473748895</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2473748895</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3937-2e2082dd6041ee9ac138a67d55d903bb335a0befd722dfd0d9a8023a3f19adb73</originalsourceid><addsrcrecordid>eNp9kc9u1DAQhy0EokvhwgMgS1wQUortSeKE22rFn6JCpRa4Wo7tdL1K4tTjqNobZ048I0-CyxYOHBhZMxrp8ydbP0KecnbCc73aBT-ecBAg75EVh7oqhGzr-2TF2qos6kawI_IIcccYB1azh-QIAKQAxlbk-2Ybw-QNjVs_BfTTgj55pPloxGC8Ts7SG5-2dI5hCNNVXi_XF5c_v_3YhK-5C3rxaU1x66z10xX1E13m2UUaHc4-6hTinqaoTaKox3lw-JquqdHo8l0TppStFNNi94_Jg14P6J7czWPy5e2bz5v3xdn5u9PN-qww0IIshBOsEdbWrOTOtdpwaHQtbVXZlkHXAVSada63UgjbW2Zb3TABGnreattJOCYvDt78oevFYVKjR-OGQU8uLKhEKUGWTdNWGX3-D7oLS5zy65SogJdSSqgz9fJAmRgQo-vVHP2o415xpm4TUrcJqd8JZfjZnXLpRmf_on8iyQA_ADd-cPv_qNSH89OPB-kv6Hyfyw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2531477736</pqid></control><display><type>article</type><title>Chronic rhinosinusitis is associated with prolonged SARS‐CoV‐2 RNA shedding in upper respiratory tract samples: A case‐control study</title><source>Wiley Online Library Journals Frontfile Complete</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Wiley Free Content</source><creator>Recalde‐Zamacona, B. ; Tomás‐Velázquez, A. ; Campo, A. ; Satrústegui‐Alzugaray, B. ; Fernández‐Alonso, M. ; Iñigo, M. ; Rodríguez‐Mateos, M. ; Di Frisco, M. ; Felgueroso, C. ; Bertó, J. ; Marín‐Oto, M. ; Alcaide, A. B. ; Zulueta, J. J. ; Seijo, L. ; Landecho, M. F.</creator><creatorcontrib>Recalde‐Zamacona, B. ; Tomás‐Velázquez, A. ; Campo, A. ; Satrústegui‐Alzugaray, B. ; Fernández‐Alonso, M. ; Iñigo, M. ; Rodríguez‐Mateos, M. ; Di Frisco, M. ; Felgueroso, C. ; Bertó, J. ; Marín‐Oto, M. ; Alcaide, A. B. ; Zulueta, J. J. ; Seijo, L. ; Landecho, M. F.</creatorcontrib><description>Background
SARS‐CoV‐2, the COVID‐19 causative agent, has infected millions of people and killed over 1.6 million worldwide. A small percentage of cases persist with prolonged positive RT‐PCR on nasopharyngeal swabs. The aim of this study was to determine risk factors for prolonged viral shedding amongst patient’s basal clinical conditions.
Methods
We have evaluated all 513 patients attended in our hospital between 1 March and 1 July. We have selected all 18 patients with prolonged viral shedding and compared them with 36 sex‐matched randomly selected controls. Demographic, treatment and clinical data were systematically collected.
Results
Global median duration of viral clearance was 25.5 days (n = 54; IQR, 22–39.3 days), 48.5 days in cases (IQR 38.7–54.9 days) and 23 days in controls (IQR 20.2–25.7), respectively. There were not observed differences in demographic, symptoms or treatment data between groups.
Chronic rhinosinusitis and atopy were more common in patients with prolonged viral shedding (67%) compared with controls (11% and 25% respectively) (P < 0.001 and P = 0.003). The use of inhaled corticosteroids was also more frequent in case group (P = 0.007). Multivariate analysis indicated that CRS (odds ratio [OR], 18.78; 95% confidence interval [95%CI], 3.89–90.59; P < 0.001) was independently associated with prolonged SARS‐CoV‐2 RNA shedding in URT samples, after adjusting for initial PCR Ct values.
Conclusion
We found that chronic rhinosinusitis and atopy might be associated with increased risk of prolonged viral shedding. If confirmed in prospective trials, this finding might have clinical implications for quarantine duration due to increased risk of pandemic spread.</description><identifier>ISSN: 0954-6820</identifier><identifier>EISSN: 1365-2796</identifier><identifier>DOI: 10.1111/joim.13237</identifier><identifier>PMID: 33372300</identifier><language>eng</language><publisher>England: Blackwell Publishing Ltd</publisher><subject>Atopy ; Chronic rhinosinusitis ; Clinical trials ; Confidence intervals ; Corticoids ; Corticosteroids ; COVID-19 ; Demographics ; inhaled corticosteroids ; Multivariate analysis ; Pandemics ; Patients ; Respiratory tract ; Rhinitis ; Rhinosinusitis ; Risk analysis ; Risk factors ; SARS‐CoV‐2 shedding ; Severe acute respiratory syndrome ; Severe acute respiratory syndrome coronavirus 2 ; Sinusitis ; upper respiratory tract ; Viral diseases</subject><ispartof>Journal of internal medicine, 2021-06, Vol.289 (6), p.921-925</ispartof><rights>2020 The Association for the Publication of the Journal of Internal Medicine</rights><rights>2020 The Association for the Publication of the Journal of Internal Medicine.</rights><rights>Copyright © 2021 The Association for the Publication of the Journal of Internal Medicine</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3937-2e2082dd6041ee9ac138a67d55d903bb335a0befd722dfd0d9a8023a3f19adb73</citedby><cites>FETCH-LOGICAL-c3937-2e2082dd6041ee9ac138a67d55d903bb335a0befd722dfd0d9a8023a3f19adb73</cites><orcidid>0000-0002-9216-4461 ; 0000-0002-2111-1020 ; 0000-0003-3234-8805</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fjoim.13237$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fjoim.13237$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,777,781,1412,1428,27905,27906,45555,45556,46390,46814</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33372300$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Recalde‐Zamacona, B.</creatorcontrib><creatorcontrib>Tomás‐Velázquez, A.</creatorcontrib><creatorcontrib>Campo, A.</creatorcontrib><creatorcontrib>Satrústegui‐Alzugaray, B.</creatorcontrib><creatorcontrib>Fernández‐Alonso, M.</creatorcontrib><creatorcontrib>Iñigo, M.</creatorcontrib><creatorcontrib>Rodríguez‐Mateos, M.</creatorcontrib><creatorcontrib>Di Frisco, M.</creatorcontrib><creatorcontrib>Felgueroso, C.</creatorcontrib><creatorcontrib>Bertó, J.</creatorcontrib><creatorcontrib>Marín‐Oto, M.</creatorcontrib><creatorcontrib>Alcaide, A. B.</creatorcontrib><creatorcontrib>Zulueta, J. J.</creatorcontrib><creatorcontrib>Seijo, L.</creatorcontrib><creatorcontrib>Landecho, M. F.</creatorcontrib><title>Chronic rhinosinusitis is associated with prolonged SARS‐CoV‐2 RNA shedding in upper respiratory tract samples: A case‐control study</title><title>Journal of internal medicine</title><addtitle>J Intern Med</addtitle><description>Background
SARS‐CoV‐2, the COVID‐19 causative agent, has infected millions of people and killed over 1.6 million worldwide. A small percentage of cases persist with prolonged positive RT‐PCR on nasopharyngeal swabs. The aim of this study was to determine risk factors for prolonged viral shedding amongst patient’s basal clinical conditions.
Methods
We have evaluated all 513 patients attended in our hospital between 1 March and 1 July. We have selected all 18 patients with prolonged viral shedding and compared them with 36 sex‐matched randomly selected controls. Demographic, treatment and clinical data were systematically collected.
Results
Global median duration of viral clearance was 25.5 days (n = 54; IQR, 22–39.3 days), 48.5 days in cases (IQR 38.7–54.9 days) and 23 days in controls (IQR 20.2–25.7), respectively. There were not observed differences in demographic, symptoms or treatment data between groups.
Chronic rhinosinusitis and atopy were more common in patients with prolonged viral shedding (67%) compared with controls (11% and 25% respectively) (P < 0.001 and P = 0.003). The use of inhaled corticosteroids was also more frequent in case group (P = 0.007). Multivariate analysis indicated that CRS (odds ratio [OR], 18.78; 95% confidence interval [95%CI], 3.89–90.59; P < 0.001) was independently associated with prolonged SARS‐CoV‐2 RNA shedding in URT samples, after adjusting for initial PCR Ct values.
Conclusion
We found that chronic rhinosinusitis and atopy might be associated with increased risk of prolonged viral shedding. If confirmed in prospective trials, this finding might have clinical implications for quarantine duration due to increased risk of pandemic spread.</description><subject>Atopy</subject><subject>Chronic rhinosinusitis</subject><subject>Clinical trials</subject><subject>Confidence intervals</subject><subject>Corticoids</subject><subject>Corticosteroids</subject><subject>COVID-19</subject><subject>Demographics</subject><subject>inhaled corticosteroids</subject><subject>Multivariate analysis</subject><subject>Pandemics</subject><subject>Patients</subject><subject>Respiratory tract</subject><subject>Rhinitis</subject><subject>Rhinosinusitis</subject><subject>Risk analysis</subject><subject>Risk factors</subject><subject>SARS‐CoV‐2 shedding</subject><subject>Severe acute respiratory syndrome</subject><subject>Severe acute respiratory syndrome coronavirus 2</subject><subject>Sinusitis</subject><subject>upper respiratory tract</subject><subject>Viral diseases</subject><issn>0954-6820</issn><issn>1365-2796</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNp9kc9u1DAQhy0EokvhwgMgS1wQUortSeKE22rFn6JCpRa4Wo7tdL1K4tTjqNobZ048I0-CyxYOHBhZMxrp8ydbP0KecnbCc73aBT-ecBAg75EVh7oqhGzr-2TF2qos6kawI_IIcccYB1azh-QIAKQAxlbk-2Ybw-QNjVs_BfTTgj55pPloxGC8Ts7SG5-2dI5hCNNVXi_XF5c_v_3YhK-5C3rxaU1x66z10xX1E13m2UUaHc4-6hTinqaoTaKox3lw-JquqdHo8l0TppStFNNi94_Jg14P6J7czWPy5e2bz5v3xdn5u9PN-qww0IIshBOsEdbWrOTOtdpwaHQtbVXZlkHXAVSada63UgjbW2Zb3TABGnreattJOCYvDt78oevFYVKjR-OGQU8uLKhEKUGWTdNWGX3-D7oLS5zy65SogJdSSqgz9fJAmRgQo-vVHP2o415xpm4TUrcJqd8JZfjZnXLpRmf_on8iyQA_ADd-cPv_qNSH89OPB-kv6Hyfyw</recordid><startdate>202106</startdate><enddate>202106</enddate><creator>Recalde‐Zamacona, B.</creator><creator>Tomás‐Velázquez, A.</creator><creator>Campo, A.</creator><creator>Satrústegui‐Alzugaray, B.</creator><creator>Fernández‐Alonso, M.</creator><creator>Iñigo, M.</creator><creator>Rodríguez‐Mateos, M.</creator><creator>Di Frisco, M.</creator><creator>Felgueroso, C.</creator><creator>Bertó, J.</creator><creator>Marín‐Oto, M.</creator><creator>Alcaide, A. B.</creator><creator>Zulueta, J. J.</creator><creator>Seijo, L.</creator><creator>Landecho, M. F.</creator><general>Blackwell Publishing Ltd</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>C1K</scope><scope>K9.</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-9216-4461</orcidid><orcidid>https://orcid.org/0000-0002-2111-1020</orcidid><orcidid>https://orcid.org/0000-0003-3234-8805</orcidid></search><sort><creationdate>202106</creationdate><title>Chronic rhinosinusitis is associated with prolonged SARS‐CoV‐2 RNA shedding in upper respiratory tract samples: A case‐control study</title><author>Recalde‐Zamacona, B. ; Tomás‐Velázquez, A. ; Campo, A. ; Satrústegui‐Alzugaray, B. ; Fernández‐Alonso, M. ; Iñigo, M. ; Rodríguez‐Mateos, M. ; Di Frisco, M. ; Felgueroso, C. ; Bertó, J. ; Marín‐Oto, M. ; Alcaide, A. B. ; Zulueta, J. J. ; Seijo, L. ; Landecho, M. F.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3937-2e2082dd6041ee9ac138a67d55d903bb335a0befd722dfd0d9a8023a3f19adb73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Atopy</topic><topic>Chronic rhinosinusitis</topic><topic>Clinical trials</topic><topic>Confidence intervals</topic><topic>Corticoids</topic><topic>Corticosteroids</topic><topic>COVID-19</topic><topic>Demographics</topic><topic>inhaled corticosteroids</topic><topic>Multivariate analysis</topic><topic>Pandemics</topic><topic>Patients</topic><topic>Respiratory tract</topic><topic>Rhinitis</topic><topic>Rhinosinusitis</topic><topic>Risk analysis</topic><topic>Risk factors</topic><topic>SARS‐CoV‐2 shedding</topic><topic>Severe acute respiratory syndrome</topic><topic>Severe acute respiratory syndrome coronavirus 2</topic><topic>Sinusitis</topic><topic>upper respiratory tract</topic><topic>Viral diseases</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Recalde‐Zamacona, B.</creatorcontrib><creatorcontrib>Tomás‐Velázquez, A.</creatorcontrib><creatorcontrib>Campo, A.</creatorcontrib><creatorcontrib>Satrústegui‐Alzugaray, B.</creatorcontrib><creatorcontrib>Fernández‐Alonso, M.</creatorcontrib><creatorcontrib>Iñigo, M.</creatorcontrib><creatorcontrib>Rodríguez‐Mateos, M.</creatorcontrib><creatorcontrib>Di Frisco, M.</creatorcontrib><creatorcontrib>Felgueroso, C.</creatorcontrib><creatorcontrib>Bertó, J.</creatorcontrib><creatorcontrib>Marín‐Oto, M.</creatorcontrib><creatorcontrib>Alcaide, A. B.</creatorcontrib><creatorcontrib>Zulueta, J. J.</creatorcontrib><creatorcontrib>Seijo, L.</creatorcontrib><creatorcontrib>Landecho, M. F.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of internal medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Recalde‐Zamacona, B.</au><au>Tomás‐Velázquez, A.</au><au>Campo, A.</au><au>Satrústegui‐Alzugaray, B.</au><au>Fernández‐Alonso, M.</au><au>Iñigo, M.</au><au>Rodríguez‐Mateos, M.</au><au>Di Frisco, M.</au><au>Felgueroso, C.</au><au>Bertó, J.</au><au>Marín‐Oto, M.</au><au>Alcaide, A. B.</au><au>Zulueta, J. J.</au><au>Seijo, L.</au><au>Landecho, M. F.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Chronic rhinosinusitis is associated with prolonged SARS‐CoV‐2 RNA shedding in upper respiratory tract samples: A case‐control study</atitle><jtitle>Journal of internal medicine</jtitle><addtitle>J Intern Med</addtitle><date>2021-06</date><risdate>2021</risdate><volume>289</volume><issue>6</issue><spage>921</spage><epage>925</epage><pages>921-925</pages><issn>0954-6820</issn><eissn>1365-2796</eissn><abstract>Background
SARS‐CoV‐2, the COVID‐19 causative agent, has infected millions of people and killed over 1.6 million worldwide. A small percentage of cases persist with prolonged positive RT‐PCR on nasopharyngeal swabs. The aim of this study was to determine risk factors for prolonged viral shedding amongst patient’s basal clinical conditions.
Methods
We have evaluated all 513 patients attended in our hospital between 1 March and 1 July. We have selected all 18 patients with prolonged viral shedding and compared them with 36 sex‐matched randomly selected controls. Demographic, treatment and clinical data were systematically collected.
Results
Global median duration of viral clearance was 25.5 days (n = 54; IQR, 22–39.3 days), 48.5 days in cases (IQR 38.7–54.9 days) and 23 days in controls (IQR 20.2–25.7), respectively. There were not observed differences in demographic, symptoms or treatment data between groups.
Chronic rhinosinusitis and atopy were more common in patients with prolonged viral shedding (67%) compared with controls (11% and 25% respectively) (P < 0.001 and P = 0.003). The use of inhaled corticosteroids was also more frequent in case group (P = 0.007). Multivariate analysis indicated that CRS (odds ratio [OR], 18.78; 95% confidence interval [95%CI], 3.89–90.59; P < 0.001) was independently associated with prolonged SARS‐CoV‐2 RNA shedding in URT samples, after adjusting for initial PCR Ct values.
Conclusion
We found that chronic rhinosinusitis and atopy might be associated with increased risk of prolonged viral shedding. If confirmed in prospective trials, this finding might have clinical implications for quarantine duration due to increased risk of pandemic spread.</abstract><cop>England</cop><pub>Blackwell Publishing Ltd</pub><pmid>33372300</pmid><doi>10.1111/joim.13237</doi><tpages>5</tpages><orcidid>https://orcid.org/0000-0002-9216-4461</orcidid><orcidid>https://orcid.org/0000-0002-2111-1020</orcidid><orcidid>https://orcid.org/0000-0003-3234-8805</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0954-6820 |
| ispartof | Journal of internal medicine, 2021-06, Vol.289 (6), p.921-925 |
| issn | 0954-6820 1365-2796 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2473748895 |
| source | Wiley Online Library Journals Frontfile Complete; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Wiley Free Content |
| subjects | Atopy Chronic rhinosinusitis Clinical trials Confidence intervals Corticoids Corticosteroids COVID-19 Demographics inhaled corticosteroids Multivariate analysis Pandemics Patients Respiratory tract Rhinitis Rhinosinusitis Risk analysis Risk factors SARS‐CoV‐2 shedding Severe acute respiratory syndrome Severe acute respiratory syndrome coronavirus 2 Sinusitis upper respiratory tract Viral diseases |
| title | Chronic rhinosinusitis is associated with prolonged SARS‐CoV‐2 RNA shedding in upper respiratory tract samples: A case‐control study |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T05%3A49%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Chronic%20rhinosinusitis%20is%20associated%20with%20prolonged%20SARS%E2%80%90CoV%E2%80%902%20RNA%20shedding%20in%20upper%20respiratory%20tract%20samples:%20A%20case%E2%80%90control%20study&rft.jtitle=Journal%20of%20internal%20medicine&rft.au=Recalde%E2%80%90Zamacona,%20B.&rft.date=2021-06&rft.volume=289&rft.issue=6&rft.spage=921&rft.epage=925&rft.pages=921-925&rft.issn=0954-6820&rft.eissn=1365-2796&rft_id=info:doi/10.1111/joim.13237&rft_dat=%3Cproquest_cross%3E2473748895%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2531477736&rft_id=info:pmid/33372300&rfr_iscdi=true |